Home Amines 170367-69-8
170367-69-8,MFCD06804538
Catalog No.:AA00AB9W

170367-69-8 | (R)-3-Boc-amino-butylamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$78.00   $54.00
- +
250mg
95%
in stock  
$129.00   $90.00
- +
500mg
95%
in stock  
$258.00   $180.00
- +
1g
95%
in stock  
$411.00   $288.00
- +
5g
95%
in stock  
$1,258.00   $881.00
- +
10g
95%
in stock  
$2,007.00   $1,405.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00AB9W
Chemical Name:
(R)-3-Boc-amino-butylamine
CAS Number:
170367-69-8
Molecular Formula:
C9H20N2O2
Molecular Weight:
188.2673
MDL Number:
MFCD06804538
SMILES:
NCC[C@H](NC(=O)OC(C)(C)C)C
Properties
Properties
 
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
164  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
0.8  

Downstream Synthesis Route
100-52-7    170367-69-8   
1(R)-methyl-3-(phenylmethylidene)aminopropylcarbamicacid,1,1-dimethylethylester 

[1]Lebreton,Luc;Jost,Eric;Carboni,Bertrand;Annat,Jocelyne;Vaultier,Michel;Dutartre,Patrick;Renaut,Patrice[JournalofMedicinalChemistry,1999,vol.42,#23,p.4749-4763]

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC;SHIONOGI&CO.,LTD.-WO2006/116764,2006,A1Locationinpatent:Page/Pagecolumn122;164

[2]Lebreton,Luc;Jost,Eric;Carboni,Bertrand;Annat,Jocelyne;Vaultier,Michel;Dutartre,Patrick;Renaut,Patrice[JournalofMedicinalChemistry,1999,vol.42,#23,p.4749-4763]

[3]Grigorenko,NikolayA.;Vepsalainen,Jouko;Jarvinen,Aki;Keinanen,Tuomo;Alhonen,Leena;Janne,Juhani;Khomutov,AlexR.[MendeleevCommunications,2005,vol.15,#4,p.142-143]

[4]Järvinen,AkiJ.;Cerrada-Gimenez,Marc;Grigorenko,NikolayA.;Khomutov,AlexR.;Vepsäläinen,JoukoJ.;Sinervirta,RiittaM.;Keinänen,TuomoA.;Alhonen,LeenaI.;Jänne,JuhaniE.[JournalofMedicinalChemistry,2006,vol.49,#1,p.399-406]

[5]Grigorenko,NikolayA.;Khomutov,AlexR.;Keinänen,TuomoA.;Järvinen,Aki;Alhonen,Leena;Jänne,Juhani;Vepsäläinen,Jouko[Tetrahedron,2007,vol.63,#10,p.2257-2262]

[6]CurrentPatentAssignee:KEZARLIFESCIENCES-WO2019/178510,2019,A1Locationinpatent:Paragraph00290

170367-69-8    550378-12-6   
3-({4-5-(2,3-dichloro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl-piperidine-1-carbonyl}-amino)-1-methyl-propyl-carbamicacid<i>tert</i>-butylester 

[1]Waal,NathanD.;Yang,Wenjin;Oslob,JohanD.;Arkin,MichelleR.;Hyde,Jennifer;Lu,Wanli;McDowell,RobertS.;Yu,ChulH.;Raimundo,BrianC.[BioorganicandMedicinalChemistryLetters,2005,vol.15,#4,p.983-987]

170367-69-8    550378-02-4   
(3-{4-5-(2,3-dichloro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl-piperidine-1-sulfonylamino}-1-methyl-propyl)-carbamicacid<i>tert</i>-butylester 

[1]Waal,NathanD.;Yang,Wenjin;Oslob,JohanD.;Arkin,MichelleR.;Hyde,Jennifer;Lu,Wanli;McDowell,RobertS.;Yu,ChulH.;Raimundo,BrianC.[BioorganicandMedicinalChemistryLetters,2005,vol.15,#4,p.983-987]

[1]Grigorenko,NikolayA.;Vepsalainen,Jouko;Jarvinen,Aki;Keinanen,Tuomo;Alhonen,Leena;Janne,Juhani;Khomutov,AlexR.[MendeleevCommunications,2005,vol.15,#4,p.142-143]

[2]Järvinen,AkiJ.;Cerrada-Gimenez,Marc;Grigorenko,NikolayA.;Khomutov,AlexR.;Vepsäläinen,JoukoJ.;Sinervirta,RiittaM.;Keinänen,TuomoA.;Alhonen,LeenaI.;Jänne,JuhaniE.[JournalofMedicinalChemistry,2006,vol.49,#1,p.399-406]

[3]Grigorenko,NikolayA.;Khomutov,AlexR.;Keinänen,TuomoA.;Järvinen,Aki;Alhonen,Leena;Jänne,Juhani;Vepsäläinen,Jouko[Tetrahedron,2007,vol.63,#10,p.2257-2262]

[4]Chamakuri,Srinivas;Santini,Conrad;Shah,ManujM.;Yang,DavidC.H.;Young,DamianW.[OrganicandBiomolecularChemistry,2020,vol.18,#43,p.8844-8849]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:170367-69-8 Molecular Formula|170367-69-8 MDL|170367-69-8 SMILES|170367-69-8 (R)-3-Boc-amino-butylamine